CHRISTY BAKER: Open Payments
NPI 1780671651 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,491 in 194 payments from 20 companies in 2025. Trend: 2023 $3,639 · 2024 $5,825 · 2025 $3,491
Food & beverage: $3,275Education: $216
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $618 |
| UCB, Inc. | 33 | $563 |
| ABBVIE INC. | 26 | $407 |
| E.R. Squibb & Sons, L.L.C. | 20 | $332 |
| Janssen Biotech, Inc. | 17 | $332 |
| PFIZER INC. | 11 | $210 |
| Regeneron Healthcare Solutions, Inc. | 10 | $164 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 9 | $151 |
| Galderma Laboratories, L.P. | 14 | $142 |
| GENZYME CORPORATION | 10 | $142 |
Products named: Bimzelx, Sotyktu, TREMFYA, DUPIXENT, SKYRIZI, Rhapsido, CIBINQO, RINVOQ.
Industry payments across KY — which companies pay providers there.
